Verge Genomics to Present at 2017 Silicon Valley Bank Healthcare Capital and Connections Summit

Alice Zhang, Co-Founder and CEO of Verge Genomics, invited to present Verge's genomic network approach at annual summit in Shanghai, China

September 11, 2017

SAN FRANCISCO — Verge Genomics, a drug discovery company utilizing genomic data for neuroscience therapeutics, announced today that Alice Zhang, its Chief Executive Officer will make a presentation at the 2017 Silicon Valley Bank Healthcare Capital and Connections Summit on September 13, 2017, at 14:30 local time (11:30 PM Pacific Time) in Shanghai, China. She will discuss Verge Genomics’ genomic network approach to drug discovery and review recent updates from the company’s robust pipeline of molecularly targeted neuroscience therapies.

 

About Verge Genomics

Verge Genomics is a next-generation drug discovery company that is using human genomic data to accelerate the discovery of treatments for neurodegeneration. Founded by scientists from leading neuro-genomics labs, the Verge team is 13 people including 11 Ph.D.s in machine learning, neuroscience, applied math, biophysics, statistics, and computational biology from UCLA, Stanford, Oxford, UCSF, and the pharmaceutical sector. For additional information, please visit our website at www.vergegenomics.com.